Skip to content

13F-HR filed by CAXTON CORP

CAXTON CORP filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 15 holding rows worth $39,590,918.

Accession
0000919574-23-003259
Filed
2023-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2023

A holdings report, 15 entries on the cover page, a total value of $39,590,918 stated on the cover page (in dollars after the unit check, H1), rows summing to $39,590,917 with VALUE read as dollars as filed, 13F file number 028-15293. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SAVARA INC805111101COM6,896,551$13,448,274dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
XERIS BIOPHARMA HOLDINGS INC98422E103COM6,039,028$9,843,616dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
SPY78462F103SHS15,947$6,528,542dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
REZOLUTE INC76200L309COMMON STOCK1,403,157$2,694,061dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
SPDR SER TR78468R556S&P OILGAS EXP17,500$2,232,825dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
VECTIVBIO HLDG AGH9060V101COM156,651$1,345,549dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
ALPS ETF TR00162Q452ALERIAN MLP29,500$1,140,175dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
MOLECULAR TEMPLATES INC608550109COM2,052,991$779,931dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
COMPASS THERAPEUTICS INC20454B104COM211,740$675,451dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
ALLAKOS INC01671P100COM86,533$385,073dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
CABALETTA BIO INC12674W109COMMON STOCK40,581$335,602dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
ELEVATION ONCOLOGY INC COM28623U101Stock68,324$129,815dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
NEWAMSTERDAM PHARMA CO NV-27N62509117WTS21,333$40,533dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
BRIDGETOWN HOLDINGS LTDG1355U121*W EXP 09/30/20239,773$6,970dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
LANVIN GROUP HOLDINGS LIMITEG5380J118W EXP 01/14/20212,000$4,500dollars as filedThe filing omitted confidential holdings, a later amendment may add them.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-23-003259this filing2023-05-15acceptance time not in the bulk data set